Imperial College London
🇧🇪Belgium
- Country
- 🇧🇪Belgium
- Ownership
- Private
- Established
- 1907-07-08
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.imperial.ac.uk
Evaluation of Musculoskeletal Microcirculation With Ultrasound
Not Applicable
Terminated
- Conditions
- Standardised Claudication Treadmill Test
- Interventions
- Procedure: Contrast enhanced ultrasoundBehavioral: Treadmill test
- First Posted Date
- 2014-03-13
- Last Posted Date
- 2020-11-25
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 5
- Registration Number
- NCT02086331
- Locations
- 🇬🇧
Charing Cross Hospital, London, United Kingdom
Reproducibility of the 11C-PBR28 PET Signal
Not Applicable
Withdrawn
- Conditions
- Neurodegenerative Disorders
- Interventions
- Drug: XBD173
- First Posted Date
- 2014-03-13
- Last Posted Date
- 2019-06-10
- Lead Sponsor
- Imperial College London
- Registration Number
- NCT02086240
- Locations
- 🇬🇧
NIHR/Wellcome Trust Imperial Clinical Research Facility, London, United Kingdom
Electrical Stimulation in Diabetic Peripheral Neuropathy
Not Applicable
Completed
- Conditions
- NMESControl
- Interventions
- Device: NMES
- First Posted Date
- 2014-03-10
- Last Posted Date
- 2020-10-27
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 14
- Registration Number
- NCT02082145
- Locations
- 🇬🇧
Academic Vascular Surgery, Charing Cross Hospital, London, United Kingdom
MODY in Young-onset Diabetes in Different Ethnicities
- Conditions
- Type 2 DiabetesMaturity Onset Diabetes of the YoungType 1 DiabetesDiabetes
- First Posted Date
- 2014-03-10
- Last Posted Date
- 2020-08-04
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 916
- Registration Number
- NCT02082132
- Locations
- 🇬🇧
Imperial College Clinical Research Facility, London, United Kingdom
Reproductive Hormones During Sustained Administration of Kisspeptin
Not Applicable
Recruiting
- Conditions
- Fertility DisordersHypothalamic Dysfunction
- Interventions
- Other: Kisspeptin 0.1Other: Kisspeptin 1.0Other: SalineOther: Kisspeptin 0.3
- First Posted Date
- 2014-03-07
- Last Posted Date
- 2023-03-15
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 76
- Registration Number
- NCT02081924
- Locations
- 🇬🇧
Imperial College NHS Healthcare Trust, London, United Kingdom
An Observational Study of Natural History of Cardiovascular Diseases
Completed
- Conditions
- StrokeHeart AttackTIACardiovascular Diseases
- First Posted Date
- 2014-03-04
- Last Posted Date
- 2019-06-12
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 456
- Registration Number
- NCT02077023
- Locations
- 🇬🇧
Imperial College London, London, United Kingdom
Immunogenicity of Three HIV GTU® MultiHIV DNA Immunisations Administered Via Intramuscular, Intradermal and Transcutaneous Routes
Phase 1
- Conditions
- HIV
- Interventions
- Biological: GTU®-multiHIV B clade
- First Posted Date
- 2014-03-03
- Last Posted Date
- 2014-03-03
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 30
- Registration Number
- NCT02075983
- Locations
- 🇬🇧
Imperial College London, Greater London, United Kingdom
Objective Randomised Blinded Investigation With Optimal Medical Therapy of Angioplasty in Stable Angina
Not Applicable
Completed
- Conditions
- Stable Angina
- Interventions
- Procedure: Coronary angioplasty
- First Posted Date
- 2014-02-13
- Last Posted Date
- 2024-01-22
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 230
- Registration Number
- NCT02062593
- Locations
- 🇬🇧
East Sussex Healthcare NHS Trust, Saint Leonards-on-sea, East Sussex, United Kingdom
🇬🇧Basildon and Thurrock University Hospitals NHS Trust, Basildon, United Kingdom
🇬🇧Royal Devon & Exeter Foundation Trust, Exeter, United Kingdom
PET Imaging in MCI Following ADT for PCa
Completed
- Conditions
- Prostate CancerMild Cognitive Impairment
- First Posted Date
- 2014-02-12
- Last Posted Date
- 2023-12-07
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 11
- Registration Number
- NCT02061345
- Locations
- 🇬🇧
Imperial College Healthcare NHS Trust, London, United Kingdom
SWS And Daytime Functioning in Chronic FatiguE Syndrome (SAFFE)
Phase 4
Completed
- Conditions
- Chronic Fatigue Syndrome
- Interventions
- Drug: Sodium OxybateOther: placebo (fresh potable water)
- First Posted Date
- 2014-02-05
- Last Posted Date
- 2020-11-18
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 13
- Registration Number
- NCT02055898
- Locations
- 🇬🇧
Wellcome CRF, Imperial College, Hammersmith Campus, London, United Kingdom
© Copyright 2025. All Rights Reserved by MedPath